TrianglePUBLICATIONS · 34721507
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Liver Cancer
- Publication date
- 2021 Sep
- First author
- Kudo M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kudo M
- type
- Author
- name
- Finn RS
- type
- Author
- name
- Morimoto M
- type
- Author
- name
- Rau KM
- type
- Author
- name
- Ikeda M
- type
- Author
- name
- Yen CJ
- type
- Author
- name
- Galle PR
- type
- Author
- name
- Llovet JM
- type
- Author
- name
- Daniele B
- type
- Author
- name
- Lim HY
- type
- Author
- name
- McIlwain DW
- type
- Author
- name
- Yoshikawa R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kudo M
- type
- Author
- name
- Finn RS
- type
- Author
- name
- Morimoto M
- type
- Author
- name
- Rau KM
- type
- Author
- name
- Ikeda M
- type
- Author
- name
- Yen CJ
- type
- Author
- name
- Galle PR
- type
- Author
- name
- Llovet JM
- type
- Author
- name
- Daniele B
- type
- Author
- name
- Lim HY
- type
- Author
- name
- McIlwain DW
- type
- Author
- name
- Yoshikawa R
- type
- Author
- bibliography ids
- nci-bib-8712203826399d669670fed6
- book metadata
- content sha256
- 9ff4f8f9a2a402d1900ea04600e898ca12fe190dee6bb9a4d80465d9d6f27a89
- document type
- citation
- dois
- 10.1159/000516605
- electronic publication date
- display
- 2021 Jul 12
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34721507
- immutable id
- pubmed:34721507@9ff4f8f9a2a402d1900ea04600e898ca12fe190dee6bb9a4d80465d9d6f27a89
- journal
- abbreviation
- Liver Cancer
- issn electronic
- 1664-5553
- issn print
- 2235-1795
- issue
- 5
- name
- Liver cancer
- nlm unique id
- 101597993
- pages
- 451-460
- volume
- 10
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34721507
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- da8a1040029a42790997f0c81db17c96b1f1309f6d5f0a704f5ec5cb8220fc4b
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2021 Sep
- precision
- month
- year
- 2021
- publication types
- Journal Article
- record status
- PubMed
- schema version
- 1.0
- title
- Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
Preserved source evidence · Not medical advice